Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonia, Ventilator-Associated | 88 | 2024 | 278 | 25.280 |
Why?
|
Sepsis | 75 | 2024 | 2594 | 11.290 |
Why?
|
Cross Infection | 60 | 2024 | 1434 | 10.180 |
Why?
|
Infection Control | 41 | 2023 | 983 | 7.610 |
Why?
|
Shock, Septic | 24 | 2024 | 760 | 7.030 |
Why?
|
Respiration, Artificial | 50 | 2024 | 2623 | 6.220 |
Why?
|
Ventilators, Mechanical | 20 | 2022 | 287 | 4.590 |
Why?
|
Anti-Bacterial Agents | 64 | 2024 | 7400 | 4.420 |
Why?
|
Intensive Care Units | 52 | 2024 | 3737 | 4.010 |
Why?
|
Population Surveillance | 34 | 2024 | 2609 | 3.800 |
Why?
|
Respiratory Tract Infections | 8 | 2024 | 1001 | 3.570 |
Why?
|
Electronic Health Records | 39 | 2024 | 4763 | 3.270 |
Why?
|
Pneumonia | 15 | 2023 | 2138 | 3.130 |
Why?
|
Hospitals | 49 | 2024 | 3929 | 2.750 |
Why?
|
Chlorhexidine | 8 | 2022 | 160 | 2.580 |
Why?
|
Masks | 7 | 2023 | 209 | 2.540 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 7 | 2021 | 250 | 2.340 |
Why?
|
Virus Diseases | 5 | 2024 | 721 | 2.330 |
Why?
|
Anti-Infective Agents, Local | 6 | 2018 | 247 | 2.180 |
Why?
|
Community-Acquired Infections | 10 | 2024 | 461 | 2.100 |
Why?
|
Pneumonia, Viral | 11 | 2024 | 3206 | 1.950 |
Why?
|
Disease Transmission, Infectious | 5 | 2022 | 558 | 1.930 |
Why?
|
Critical Care | 21 | 2024 | 2699 | 1.870 |
Why?
|
Aerosols | 7 | 2024 | 633 | 1.600 |
Why?
|
Humans | 332 | 2024 | 760261 | 1.590 |
Why?
|
Influenza, Human | 9 | 2024 | 1532 | 1.520 |
Why?
|
Ventilator-Induced Lung Injury | 6 | 2021 | 119 | 1.510 |
Why?
|
Coronavirus Infections | 8 | 2020 | 3086 | 1.480 |
Why?
|
Quality Indicators, Health Care | 9 | 2023 | 1822 | 1.470 |
Why?
|
Antibiotic Prophylaxis | 4 | 2024 | 642 | 1.380 |
Why?
|
Massachusetts | 27 | 2024 | 8805 | 1.360 |
Why?
|
Communicable Diseases | 6 | 2021 | 879 | 1.350 |
Why?
|
Hospital Mortality | 26 | 2024 | 5420 | 1.280 |
Why?
|
Viruses | 2 | 2024 | 376 | 1.240 |
Why?
|
Communicable Disease Control | 3 | 2020 | 844 | 1.230 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2023 | 364 | 1.220 |
Why?
|
Chlamydia Infections | 3 | 2021 | 362 | 1.220 |
Why?
|
Public Health Informatics | 3 | 2020 | 109 | 1.210 |
Why?
|
Drug Resistance, Multiple, Bacterial | 9 | 2021 | 586 | 1.200 |
Why?
|
Disease Notification | 6 | 2022 | 98 | 1.190 |
Why?
|
Sentinel Surveillance | 5 | 2023 | 293 | 1.190 |
Why?
|
Bacteremia | 5 | 2023 | 979 | 1.180 |
Why?
|
Health Personnel | 11 | 2024 | 3310 | 1.160 |
Why?
|
Lyme Disease | 2 | 2024 | 630 | 1.120 |
Why?
|
United States | 86 | 2024 | 72363 | 1.120 |
Why?
|
Pandemics | 20 | 2024 | 8621 | 1.110 |
Why?
|
Algorithms | 20 | 2024 | 13967 | 1.100 |
Why?
|
Critical Illness | 12 | 2023 | 2709 | 1.100 |
Why?
|
Quality Improvement | 11 | 2022 | 3840 | 1.090 |
Why?
|
Inappropriate Prescribing | 4 | 2022 | 209 | 1.070 |
Why?
|
Anti-Infective Agents | 6 | 2023 | 982 | 1.030 |
Why?
|
Intubation, Intratracheal | 6 | 2021 | 1328 | 1.030 |
Why?
|
Clostridium Infections | 5 | 2021 | 557 | 1.030 |
Why?
|
Gram-Negative Bacterial Infections | 3 | 2018 | 238 | 1.000 |
Why?
|
Behavioral Risk Factor Surveillance System | 4 | 2024 | 208 | 0.990 |
Why?
|
Mandatory Programs | 2 | 2022 | 86 | 0.920 |
Why?
|
Metapneumovirus | 1 | 2024 | 28 | 0.920 |
Why?
|
Paramyxoviridae Infections | 1 | 2024 | 57 | 0.900 |
Why?
|
Laboratories | 2 | 2021 | 461 | 0.900 |
Why?
|
Toothbrushing | 1 | 2024 | 46 | 0.900 |
Why?
|
Ralstonia pickettii | 1 | 2022 | 4 | 0.860 |
Why?
|
Burkholderia cepacia | 1 | 2022 | 22 | 0.850 |
Why?
|
Water Purification | 1 | 2023 | 58 | 0.840 |
Why?
|
Burkholderia cepacia complex | 1 | 2022 | 24 | 0.840 |
Why?
|
Clinical Laboratory Techniques | 4 | 2020 | 749 | 0.840 |
Why?
|
Bacterial Infections | 4 | 2021 | 1402 | 0.830 |
Why?
|
Benchmarking | 5 | 2023 | 1043 | 0.830 |
Why?
|
Burkholderia Infections | 1 | 2022 | 41 | 0.820 |
Why?
|
Retrospective Studies | 67 | 2024 | 80301 | 0.780 |
Why?
|
Hemorrhagic Fever, Ebola | 3 | 2016 | 420 | 0.770 |
Why?
|
Pseudomonas Infections | 2 | 2023 | 623 | 0.760 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2023 | 149 | 0.760 |
Why?
|
Veterans Health | 1 | 2023 | 216 | 0.760 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2022 | 1455 | 0.760 |
Why?
|
Hospitalization | 23 | 2024 | 10761 | 0.710 |
Why?
|
Benzodiazepines | 2 | 2016 | 1132 | 0.690 |
Why?
|
Air Microbiology | 1 | 2020 | 94 | 0.690 |
Why?
|
Health Policy | 6 | 2022 | 2678 | 0.680 |
Why?
|
Gonorrhea | 2 | 2021 | 342 | 0.680 |
Why?
|
Oral Hygiene | 2 | 2017 | 129 | 0.670 |
Why?
|
Adult | 83 | 2024 | 219847 | 0.660 |
Why?
|
Societies | 3 | 2019 | 108 | 0.660 |
Why?
|
Delayed Diagnosis | 2 | 2020 | 463 | 0.650 |
Why?
|
Pneumonia, Bacterial | 3 | 2016 | 319 | 0.650 |
Why?
|
Incidence | 27 | 2024 | 21378 | 0.650 |
Why?
|
Vancomycin | 2 | 2019 | 503 | 0.640 |
Why?
|
Insurance Claim Review | 2 | 2014 | 737 | 0.630 |
Why?
|
Mouthwashes | 2 | 2018 | 57 | 0.620 |
Why?
|
Delirium | 4 | 2018 | 1651 | 0.620 |
Why?
|
Daptomycin | 1 | 2018 | 71 | 0.610 |
Why?
|
Indenes | 1 | 2018 | 58 | 0.590 |
Why?
|
Enterococcus faecium | 1 | 2018 | 101 | 0.590 |
Why?
|
Male | 97 | 2024 | 359413 | 0.590 |
Why?
|
Inhalation Exposure | 1 | 2020 | 429 | 0.580 |
Why?
|
Female | 98 | 2024 | 391011 | 0.580 |
Why?
|
Surgical Wound Infection | 4 | 2016 | 1529 | 0.570 |
Why?
|
Practice Guidelines as Topic | 17 | 2024 | 7468 | 0.570 |
Why?
|
Aged | 64 | 2024 | 168995 | 0.560 |
Why?
|
Mass Screening | 4 | 2020 | 5422 | 0.560 |
Why?
|
Hepatitis B | 3 | 2013 | 701 | 0.560 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 3 | 2022 | 33 | 0.560 |
Why?
|
Severity of Illness Index | 14 | 2022 | 15827 | 0.550 |
Why?
|
Propensity Score | 1 | 2024 | 1918 | 0.550 |
Why?
|
Risk Adjustment | 3 | 2021 | 601 | 0.550 |
Why?
|
Health Planning | 2 | 2014 | 232 | 0.540 |
Why?
|
Middle Aged | 73 | 2024 | 220175 | 0.530 |
Why?
|
Iatrogenic Disease | 1 | 2019 | 538 | 0.530 |
Why?
|
Clinical Coding | 5 | 2020 | 181 | 0.530 |
Why?
|
Catheter-Related Infections | 4 | 2024 | 272 | 0.520 |
Why?
|
Guideline Adherence | 5 | 2021 | 2283 | 0.510 |
Why?
|
Multiple Organ Failure | 6 | 2023 | 387 | 0.510 |
Why?
|
Universal Precautions | 1 | 2014 | 34 | 0.480 |
Why?
|
Government Regulation | 2 | 2022 | 526 | 0.480 |
Why?
|
Glottis | 1 | 2016 | 214 | 0.480 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2012 | 936 | 0.460 |
Why?
|
Workplace | 1 | 2020 | 858 | 0.460 |
Why?
|
Medicare | 8 | 2024 | 6771 | 0.460 |
Why?
|
Hypnotics and Sedatives | 3 | 2016 | 1178 | 0.460 |
Why?
|
Home Care Services | 2 | 2017 | 653 | 0.460 |
Why?
|
Patient Care Management | 2 | 2014 | 303 | 0.460 |
Why?
|
Occupational Exposure | 2 | 2021 | 1809 | 0.460 |
Why?
|
Ventilator Weaning | 1 | 2015 | 161 | 0.450 |
Why?
|
Length of Stay | 12 | 2024 | 6472 | 0.450 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1228 | 0.440 |
Why?
|
Emergency Medical Services | 3 | 2022 | 1927 | 0.440 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2020 | 750 | 0.440 |
Why?
|
Time Factors | 16 | 2024 | 40133 | 0.440 |
Why?
|
Risk Factors | 28 | 2022 | 74269 | 0.430 |
Why?
|
Propofol | 2 | 2016 | 608 | 0.430 |
Why?
|
Melatonin | 1 | 2018 | 668 | 0.420 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2024 | 695 | 0.420 |
Why?
|
Endocarditis | 1 | 2017 | 351 | 0.420 |
Why?
|
Disease Outbreaks | 6 | 2023 | 1759 | 0.420 |
Why?
|
Drug Utilization | 1 | 2019 | 1195 | 0.420 |
Why?
|
Hospital Administration | 1 | 2016 | 354 | 0.410 |
Why?
|
Observer Variation | 2 | 2016 | 2596 | 0.410 |
Why?
|
Critical Pathways | 1 | 2016 | 475 | 0.410 |
Why?
|
Respiratory Syncytial Viruses | 2 | 2024 | 167 | 0.400 |
Why?
|
Clinical Protocols | 2 | 2017 | 1439 | 0.400 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2014 | 343 | 0.400 |
Why?
|
Brain Injuries | 1 | 2024 | 2044 | 0.390 |
Why?
|
Occupational Diseases | 1 | 2020 | 1484 | 0.390 |
Why?
|
Prevalence | 14 | 2024 | 15687 | 0.390 |
Why?
|
Hepatitis A | 1 | 2012 | 133 | 0.390 |
Why?
|
Risk Management | 1 | 2015 | 558 | 0.390 |
Why?
|
Neuralgia, Postherpetic | 1 | 2011 | 41 | 0.390 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2015 | 488 | 0.390 |
Why?
|
Dexmedetomidine | 1 | 2016 | 315 | 0.380 |
Why?
|
Conscious Sedation | 1 | 2016 | 529 | 0.380 |
Why?
|
Emergency Service, Hospital | 6 | 2023 | 7809 | 0.350 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2024 | 621 | 0.350 |
Why?
|
Hospitals, Community | 1 | 2012 | 367 | 0.340 |
Why?
|
Ceftazidime | 3 | 2021 | 57 | 0.330 |
Why?
|
Decision Support Systems, Clinical | 2 | 2016 | 1162 | 0.330 |
Why?
|
Silver Compounds | 1 | 2008 | 23 | 0.330 |
Why?
|
Herpes Zoster | 1 | 2011 | 251 | 0.320 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2014 | 3451 | 0.310 |
Why?
|
Patient Compliance | 1 | 2019 | 2689 | 0.310 |
Why?
|
HIV Infections | 5 | 2024 | 17159 | 0.310 |
Why?
|
Academic Medical Centers | 6 | 2022 | 2753 | 0.310 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2127 | 0.300 |
Why?
|
Pulmonary Edema | 3 | 2016 | 409 | 0.300 |
Why?
|
Urinary Tract Infections | 3 | 2024 | 817 | 0.300 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3618 | 0.290 |
Why?
|
Equipment Contamination | 1 | 2008 | 178 | 0.290 |
Why?
|
Medical Records Systems, Computerized | 3 | 2014 | 1191 | 0.290 |
Why?
|
Exercise | 2 | 2021 | 5783 | 0.280 |
Why?
|
Diabetes Mellitus | 3 | 2022 | 5884 | 0.280 |
Why?
|
Health Services Research | 2 | 2015 | 1811 | 0.280 |
Why?
|
Young Adult | 17 | 2024 | 58673 | 0.280 |
Why?
|
Early Diagnosis | 3 | 2020 | 1181 | 0.270 |
Why?
|
Boston | 8 | 2021 | 9282 | 0.270 |
Why?
|
Vaccines | 1 | 2015 | 833 | 0.270 |
Why?
|
Water | 2 | 2022 | 1402 | 0.270 |
Why?
|
Surgical Procedures, Operative | 3 | 2016 | 1919 | 0.260 |
Why?
|
Reproducibility of Results | 11 | 2023 | 20048 | 0.260 |
Why?
|
Hypertension | 2 | 2023 | 8595 | 0.250 |
Why?
|
Chronic Disease | 4 | 2024 | 9283 | 0.250 |
Why?
|
Antipsychotic Agents | 1 | 2018 | 3061 | 0.250 |
Why?
|
Aged, 80 and over | 18 | 2021 | 58947 | 0.250 |
Why?
|
Adrenal Cortex Hormones | 2 | 2021 | 1870 | 0.240 |
Why?
|
Electronics | 2 | 2023 | 317 | 0.240 |
Why?
|
Diagnostic Errors | 3 | 2020 | 1266 | 0.240 |
Why?
|
International Classification of Diseases | 3 | 2020 | 884 | 0.240 |
Why?
|
Primary Health Care | 5 | 2022 | 4649 | 0.240 |
Why?
|
Asthma | 2 | 2024 | 6167 | 0.230 |
Why?
|
Sensitivity and Specificity | 9 | 2020 | 14656 | 0.230 |
Why?
|
Delivery of Health Care | 7 | 2023 | 5324 | 0.230 |
Why?
|
Bacteria | 1 | 2014 | 2196 | 0.220 |
Why?
|
Cohort Studies | 15 | 2023 | 41317 | 0.220 |
Why?
|
Staphylococcal Infections | 4 | 2023 | 1405 | 0.220 |
Why?
|
Lactic Acid | 5 | 2021 | 1132 | 0.220 |
Why?
|
Proton Pump Inhibitors | 2 | 2020 | 551 | 0.220 |
Why?
|
Pulmonary Atelectasis | 2 | 2015 | 143 | 0.220 |
Why?
|
Hospitals, University | 3 | 2014 | 568 | 0.220 |
Why?
|
Asymptomatic Infections | 2 | 2021 | 131 | 0.210 |
Why?
|
Personnel, Hospital | 2 | 2021 | 285 | 0.210 |
Why?
|
Fluid Therapy | 4 | 2022 | 593 | 0.210 |
Why?
|
Carbapenems | 2 | 2020 | 123 | 0.210 |
Why?
|
Rhinovirus | 1 | 2024 | 202 | 0.200 |
Why?
|
Meta-Analysis as Topic | 2 | 2017 | 1375 | 0.200 |
Why?
|
Severe Acute Respiratory Syndrome | 2 | 2020 | 137 | 0.200 |
Why?
|
Ice | 1 | 2023 | 102 | 0.200 |
Why?
|
Infant, Newborn | 10 | 2023 | 26168 | 0.200 |
Why?
|
England | 1 | 2023 | 526 | 0.200 |
Why?
|
Medical Audit | 4 | 2018 | 453 | 0.200 |
Why?
|
Quality of Health Care | 3 | 2018 | 4361 | 0.200 |
Why?
|
beta-Lactams | 1 | 2023 | 157 | 0.200 |
Why?
|
Azabicyclo Compounds | 2 | 2021 | 68 | 0.190 |
Why?
|
Reimbursement, Incentive | 2 | 2024 | 543 | 0.190 |
Why?
|
Drug Contamination | 1 | 2022 | 152 | 0.190 |
Why?
|
Ventilation | 1 | 2021 | 128 | 0.190 |
Why?
|
Information Dissemination | 2 | 2023 | 1132 | 0.190 |
Why?
|
Patient Positioning | 2 | 2016 | 327 | 0.190 |
Why?
|
Adolescent | 15 | 2024 | 87747 | 0.180 |
Why?
|
Child, Preschool | 9 | 2024 | 42034 | 0.180 |
Why?
|
Water-Electrolyte Balance | 1 | 2022 | 334 | 0.180 |
Why?
|
Models, Statistical | 1 | 2015 | 5073 | 0.180 |
Why?
|
Rural Health Services | 1 | 2024 | 381 | 0.180 |
Why?
|
Developing Countries | 1 | 2012 | 2880 | 0.170 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15273 | 0.170 |
Why?
|
Obesity | 3 | 2022 | 12915 | 0.170 |
Why?
|
Hospitals, Teaching | 3 | 2019 | 1166 | 0.170 |
Why?
|
Adenoviridae | 1 | 2024 | 1084 | 0.170 |
Why?
|
Regression Analysis | 3 | 2015 | 6361 | 0.170 |
Why?
|
Respiration | 2 | 2016 | 1648 | 0.170 |
Why?
|
Immunization, Secondary | 1 | 2022 | 366 | 0.170 |
Why?
|
Catalysis | 1 | 2021 | 775 | 0.170 |
Why?
|
Reference Values | 3 | 2021 | 4920 | 0.160 |
Why?
|
Child | 12 | 2024 | 79758 | 0.160 |
Why?
|
Oxygen | 4 | 2024 | 4189 | 0.160 |
Why?
|
Public Health | 4 | 2023 | 2655 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2014 | 12281 | 0.160 |
Why?
|
Thromboembolism | 2 | 2016 | 1016 | 0.160 |
Why?
|
Infant | 10 | 2019 | 36030 | 0.160 |
Why?
|
Histamine H2 Antagonists | 1 | 2020 | 167 | 0.160 |
Why?
|
Prospective Studies | 9 | 2023 | 54263 | 0.160 |
Why?
|
Public Health Administration | 3 | 2015 | 243 | 0.160 |
Why?
|
Peptic Ulcer | 1 | 2020 | 219 | 0.160 |
Why?
|
Seasons | 1 | 2024 | 1523 | 0.150 |
Why?
|
Corynebacterium | 1 | 2018 | 47 | 0.150 |
Why?
|
Corynebacterium Infections | 1 | 2018 | 27 | 0.150 |
Why?
|
Syphilis | 1 | 2021 | 240 | 0.150 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2023 | 623 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1576 | 0.150 |
Why?
|
Pseudomonas aeruginosa | 2 | 2023 | 1275 | 0.150 |
Why?
|
Respiratory System | 1 | 2021 | 554 | 0.150 |
Why?
|
Logistic Models | 7 | 2021 | 13311 | 0.150 |
Why?
|
Tuberculosis | 1 | 2010 | 2003 | 0.150 |
Why?
|
Diagnosis, Differential | 4 | 2021 | 12968 | 0.150 |
Why?
|
Insurance Claim Reporting | 2 | 2017 | 165 | 0.150 |
Why?
|
Pharmacoepidemiology | 1 | 2021 | 348 | 0.140 |
Why?
|
Inpatients | 3 | 2024 | 2578 | 0.140 |
Why?
|
Vasoconstrictor Agents | 2 | 2021 | 651 | 0.140 |
Why?
|
Drug Resistance, Microbial | 1 | 2020 | 858 | 0.140 |
Why?
|
Amikacin | 1 | 2016 | 48 | 0.140 |
Why?
|
France | 1 | 2018 | 511 | 0.140 |
Why?
|
Treatment Outcome | 11 | 2023 | 64947 | 0.140 |
Why?
|
Population Growth | 1 | 2016 | 50 | 0.140 |
Why?
|
Standard of Care | 1 | 2020 | 552 | 0.130 |
Why?
|
Colistin | 1 | 2016 | 45 | 0.130 |
Why?
|
Administration, Oral | 3 | 2023 | 4044 | 0.130 |
Why?
|
Particle Size | 1 | 2020 | 1643 | 0.130 |
Why?
|
Models, Theoretical | 1 | 2008 | 3561 | 0.130 |
Why?
|
Maryland | 1 | 2016 | 275 | 0.130 |
Why?
|
Respiratory Therapy | 1 | 2016 | 127 | 0.130 |
Why?
|
Patellar Ligament | 1 | 2016 | 64 | 0.130 |
Why?
|
Culture Techniques | 1 | 2016 | 530 | 0.130 |
Why?
|
Drug Combinations | 2 | 2021 | 2024 | 0.130 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2002 | 693 | 0.130 |
Why?
|
Computer Systems | 2 | 2014 | 470 | 0.120 |
Why?
|
Acinetobacter Infections | 1 | 2015 | 71 | 0.120 |
Why?
|
Ulcer | 1 | 2016 | 205 | 0.120 |
Why?
|
Sexually Transmitted Diseases | 1 | 2021 | 628 | 0.120 |
Why?
|
Buprenorphine | 1 | 2023 | 653 | 0.120 |
Why?
|
Pennsylvania | 1 | 2016 | 615 | 0.120 |
Why?
|
Coma | 1 | 2018 | 487 | 0.120 |
Why?
|
Ambulatory Care | 2 | 2019 | 2783 | 0.120 |
Why?
|
Safety Management | 1 | 2020 | 760 | 0.120 |
Why?
|
Ohio | 1 | 2015 | 333 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 3804 | 0.120 |
Why?
|
Case-Control Studies | 5 | 2022 | 22041 | 0.120 |
Why?
|
Selection Bias | 1 | 2016 | 358 | 0.120 |
Why?
|
Sexual Partners | 1 | 2019 | 750 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 10340 | 0.120 |
Why?
|
Biota | 1 | 2014 | 23 | 0.120 |
Why?
|
Terminology as Topic | 2 | 2019 | 1534 | 0.120 |
Why?
|
Anti-HIV Agents | 2 | 2021 | 4492 | 0.120 |
Why?
|
Quarantine | 1 | 2016 | 176 | 0.110 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1067 | 0.110 |
Why?
|
Occupational Health | 1 | 2020 | 804 | 0.110 |
Why?
|
Hospitals, Special | 1 | 2014 | 90 | 0.110 |
Why?
|
Influenza Vaccines | 1 | 2021 | 770 | 0.110 |
Why?
|
Drainage | 2 | 2017 | 1161 | 0.110 |
Why?
|
Patient Acceptance of Health Care | 2 | 2019 | 3159 | 0.110 |
Why?
|
Microbial Sensitivity Tests | 4 | 2022 | 1952 | 0.110 |
Why?
|
Probiotics | 1 | 2017 | 377 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2063 | 0.110 |
Why?
|
Antifungal Agents | 2 | 2016 | 746 | 0.110 |
Why?
|
Peroneal Nerve | 1 | 2013 | 76 | 0.110 |
Why?
|
Viral Load | 1 | 2022 | 3323 | 0.110 |
Why?
|
Acute Disease | 3 | 2012 | 7268 | 0.110 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1156 | 0.110 |
Why?
|
HIV | 1 | 2020 | 1579 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2018 | 909 | 0.100 |
Why?
|
Polyarteritis Nodosa | 1 | 2013 | 70 | 0.100 |
Why?
|
Homosexuality, Male | 1 | 2020 | 1269 | 0.100 |
Why?
|
Vaccination | 2 | 2022 | 3360 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2019 | 1548 | 0.100 |
Why?
|
Computer Security | 1 | 2014 | 260 | 0.100 |
Why?
|
Informed Consent | 1 | 2018 | 1007 | 0.100 |
Why?
|
Patient Admission | 2 | 2021 | 1384 | 0.100 |
Why?
|
Comorbidity | 4 | 2022 | 10552 | 0.100 |
Why?
|
Odds Ratio | 4 | 2021 | 9712 | 0.100 |
Why?
|
Drug Administration Routes | 2 | 2021 | 150 | 0.100 |
Why?
|
New York | 1 | 2014 | 874 | 0.100 |
Why?
|
Weight Gain | 1 | 2022 | 2347 | 0.100 |
Why?
|
Posture | 1 | 2015 | 954 | 0.100 |
Why?
|
Trust | 1 | 2016 | 528 | 0.090 |
Why?
|
Bone Transplantation | 1 | 2016 | 922 | 0.090 |
Why?
|
Gait Disorders, Neurologic | 1 | 2013 | 238 | 0.090 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 725 | 0.090 |
Why?
|
Area Under Curve | 1 | 2015 | 1635 | 0.090 |
Why?
|
Poisson Distribution | 1 | 2012 | 507 | 0.090 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2010 | 24 | 0.090 |
Why?
|
Liver Function Tests | 1 | 2012 | 524 | 0.090 |
Why?
|
Hair | 1 | 2014 | 492 | 0.090 |
Why?
|
Diagnosis-Related Groups | 1 | 2012 | 450 | 0.090 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 718 | 0.090 |
Why?
|
Carrier State | 1 | 2014 | 525 | 0.090 |
Why?
|
Proportional Hazards Models | 4 | 2019 | 12532 | 0.090 |
Why?
|
Equipment and Supplies | 1 | 2012 | 275 | 0.090 |
Why?
|
Ascomycota | 1 | 2010 | 82 | 0.090 |
Why?
|
Silver | 1 | 2010 | 120 | 0.080 |
Why?
|
beta-Lactamases | 2 | 2022 | 304 | 0.080 |
Why?
|
Epidemiologic Methods | 1 | 2014 | 1344 | 0.080 |
Why?
|
Group Practice | 1 | 2010 | 151 | 0.080 |
Why?
|
Multivariate Analysis | 6 | 2020 | 12156 | 0.080 |
Why?
|
Documentation | 1 | 2015 | 892 | 0.080 |
Why?
|
Health Care Costs | 2 | 2020 | 3257 | 0.080 |
Why?
|
Risk | 3 | 2021 | 9629 | 0.080 |
Why?
|
North Carolina | 2 | 2019 | 325 | 0.080 |
Why?
|
Blood Transfusion | 1 | 2015 | 1328 | 0.080 |
Why?
|
Health Behavior | 2 | 2017 | 2621 | 0.080 |
Why?
|
Patient Discharge | 3 | 2023 | 3475 | 0.080 |
Why?
|
Age Distribution | 3 | 2019 | 2893 | 0.080 |
Why?
|
Sex Factors | 3 | 2019 | 10530 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2932 | 0.080 |
Why?
|
Immunoglobulins | 2 | 2021 | 863 | 0.080 |
Why?
|
Lung Transplantation | 1 | 2018 | 1304 | 0.080 |
Why?
|
Disinfection | 1 | 2010 | 209 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2135 | 0.080 |
Why?
|
Health Maintenance Organizations | 1 | 2010 | 660 | 0.070 |
Why?
|
Patient Care Team | 2 | 2016 | 2510 | 0.070 |
Why?
|
Pregnancy | 2 | 2020 | 29725 | 0.070 |
Why?
|
Urinary Catheterization | 1 | 2008 | 200 | 0.070 |
Why?
|
Risk Assessment | 6 | 2021 | 24086 | 0.070 |
Why?
|
Review Literature as Topic | 1 | 2009 | 350 | 0.070 |
Why?
|
Gentian Violet | 1 | 2007 | 29 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6499 | 0.070 |
Why?
|
Phenazines | 1 | 2007 | 56 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3568 | 0.070 |
Why?
|
Attitude to Health | 1 | 2016 | 2028 | 0.070 |
Why?
|
Immunoglobulin M | 1 | 2012 | 1529 | 0.070 |
Why?
|
Resuscitation | 2 | 2021 | 662 | 0.070 |
Why?
|
Immunocompromised Host | 3 | 2019 | 857 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8487 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2021 | 12762 | 0.070 |
Why?
|
Age Factors | 3 | 2019 | 18415 | 0.060 |
Why?
|
Survival Analysis | 1 | 2018 | 10185 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39254 | 0.060 |
Why?
|
Transplantation, Homologous | 1 | 2014 | 4814 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2018 | 3598 | 0.060 |
Why?
|
Bacteriological Techniques | 2 | 2016 | 279 | 0.060 |
Why?
|
Data Collection | 1 | 2014 | 3317 | 0.060 |
Why?
|
Anesthesia | 1 | 2015 | 1584 | 0.060 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 2178 | 0.060 |
Why?
|
Medical Records | 1 | 2010 | 1407 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2024 | 2325 | 0.060 |
Why?
|
Body Mass Index | 3 | 2022 | 12901 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8058 | 0.060 |
Why?
|
Biofilms | 1 | 2008 | 622 | 0.060 |
Why?
|
Monobactams | 1 | 2023 | 16 | 0.060 |
Why?
|
Patient Isolators | 1 | 2023 | 12 | 0.060 |
Why?
|
Louisiana | 1 | 2023 | 104 | 0.060 |
Why?
|
Frontal Lobe | 1 | 2010 | 1422 | 0.060 |
Why?
|
Indiana | 1 | 2023 | 93 | 0.060 |
Why?
|
Registries | 2 | 2020 | 8449 | 0.060 |
Why?
|
Catheterization, Central Venous | 1 | 2008 | 526 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2021 | 4900 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2017 | 12412 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5507 | 0.050 |
Why?
|
Aspergillus | 1 | 2023 | 92 | 0.050 |
Why?
|
Insurance, Health | 1 | 2015 | 2500 | 0.050 |
Why?
|
Enterobacter | 1 | 2022 | 46 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5201 | 0.050 |
Why?
|
Oseltamivir | 1 | 2022 | 77 | 0.050 |
Why?
|
Neoplasms | 2 | 2021 | 22066 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11891 | 0.050 |
Why?
|
Glucagon | 1 | 2003 | 532 | 0.050 |
Why?
|
Heart Failure | 2 | 2022 | 11835 | 0.050 |
Why?
|
Visitors to Patients | 1 | 2020 | 36 | 0.040 |
Why?
|
Software | 1 | 2014 | 4420 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 2 | 2020 | 1054 | 0.040 |
Why?
|
Acute Kidney Injury | 1 | 2012 | 1935 | 0.040 |
Why?
|
Hospital Bed Capacity | 1 | 2021 | 210 | 0.040 |
Why?
|
Rats | 1 | 2016 | 23695 | 0.040 |
Why?
|
Bronchoalveolar Lavage | 1 | 2020 | 129 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14482 | 0.040 |
Why?
|
Death Certificates | 1 | 2020 | 167 | 0.040 |
Why?
|
Medically Underserved Area | 1 | 2022 | 258 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 281 | 0.040 |
Why?
|
Bronchitis, Chronic | 1 | 2019 | 82 | 0.040 |
Why?
|
Opiate Substitution Treatment | 1 | 2023 | 435 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2003 | 509 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 546 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2023 | 2235 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6797 | 0.040 |
Why?
|
Medical History Taking | 1 | 2002 | 773 | 0.040 |
Why?
|
Australia | 1 | 2022 | 1288 | 0.040 |
Why?
|
Paralysis | 1 | 2019 | 251 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 149 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2024 | 2569 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1723 | 0.040 |
Why?
|
Disease Management | 2 | 2018 | 2508 | 0.040 |
Why?
|
Plasmids | 1 | 2022 | 2277 | 0.040 |
Why?
|
Gram-Negative Bacteria | 1 | 2018 | 272 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18134 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2021 | 566 | 0.030 |
Why?
|
Fluoroquinolones | 1 | 2018 | 309 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2021 | 398 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5790 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2023 | 833 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25928 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2003 | 888 | 0.030 |
Why?
|
Physical Examination | 1 | 2002 | 1244 | 0.030 |
Why?
|
China | 1 | 2022 | 2340 | 0.030 |
Why?
|
Acinetobacter | 1 | 2015 | 39 | 0.030 |
Why?
|
Dexamethasone | 1 | 2023 | 1928 | 0.030 |
Why?
|
Thinness | 1 | 2019 | 491 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2002 | 1295 | 0.030 |
Why?
|
Linear Models | 2 | 2018 | 5876 | 0.030 |
Why?
|
Chest Pain | 1 | 2002 | 1106 | 0.030 |
Why?
|
Biomedical Research | 1 | 2010 | 3421 | 0.030 |
Why?
|
Inservice Training | 1 | 2017 | 376 | 0.030 |
Why?
|
Hepatitis, Viral, Human | 1 | 2015 | 141 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 8018 | 0.030 |
Why?
|
Pulmonary Emphysema | 1 | 2019 | 688 | 0.030 |
Why?
|
Animals | 2 | 2016 | 167940 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12806 | 0.030 |
Why?
|
Intention | 1 | 2016 | 337 | 0.030 |
Why?
|
Hepatitis B Core Antigens | 1 | 2013 | 88 | 0.030 |
Why?
|
Surgery Department, Hospital | 1 | 2014 | 177 | 0.030 |
Why?
|
Causality | 1 | 2019 | 1241 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 1462 | 0.030 |
Why?
|
Genome, Bacterial | 1 | 2018 | 770 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 29636 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2020 | 1395 | 0.030 |
Why?
|
Culture | 1 | 2016 | 622 | 0.030 |
Why?
|
Automation | 1 | 2014 | 581 | 0.030 |
Why?
|
Neural Conduction | 1 | 2013 | 441 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1882 | 0.020 |
Why?
|
Oral Health | 1 | 2017 | 484 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2295 | 0.020 |
Why?
|
Glucose | 1 | 2003 | 4361 | 0.020 |
Why?
|
Hemodynamics | 1 | 2021 | 4169 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8553 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 1013 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2013 | 413 | 0.020 |
Why?
|
Cost of Illness | 1 | 2019 | 1940 | 0.020 |
Why?
|
beta-Glucans | 1 | 2010 | 121 | 0.020 |
Why?
|
Program Evaluation | 1 | 2018 | 2494 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2010 | 693 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3061 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1884 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6545 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2022 | 3822 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 830 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4276 | 0.020 |
Why?
|
Morbidity | 1 | 2013 | 1765 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2015 | 832 | 0.020 |
Why?
|
California | 1 | 2011 | 1416 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3206 | 0.020 |
Why?
|
Blood Glucose | 1 | 2021 | 6375 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 3762 | 0.020 |
Why?
|
Urban Population | 1 | 2014 | 2021 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 3967 | 0.020 |
Why?
|
Mortality | 1 | 2017 | 2916 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16543 | 0.020 |
Why?
|
Fever | 1 | 2013 | 1618 | 0.020 |
Why?
|
Microscopy | 1 | 2010 | 881 | 0.020 |
Why?
|
Triazoles | 1 | 2010 | 904 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1200 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2011 | 2698 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2013 | 2273 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2003 | 679 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 7803 | 0.010 |
Why?
|
Natural Language Processing | 1 | 2008 | 1136 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 6965 | 0.010 |
Why?
|
Pyrimidines | 1 | 2010 | 3011 | 0.010 |
Why?
|
Pain | 1 | 2013 | 5066 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4168 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2008 | 3696 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2010 | 4215 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36247 | 0.000 |
Why?
|